SymPerturb converts symptom-network structure into testable intervention priorities
Zhu, Z.; Yu, J.; Hu, T.; Yang, Z.; Wang, J.
Show abstract
Symptom networks encode conditional dependence but do not by themselves identify causal or clinically actionable intervention targets. We introduce SymPerturb, a virtual-perturbation framework that distinguishes four primitive perturbation operators - virtual knockout, virtual knockdown, edge-level communication blocking and node-centred communication blocking - from three analytic procedures - virtual dosage perturbation, combination perturbation and sequence optimisation. The reference Gaussian implementation is embedded in a general location-scale map with symptom-specific target anchors, making explicit that zero anchoring and linked mean-variance attenuation are modelling choices. Seven utility outcomes quantify downstream efficacy, dose efficiency, breadth, cross-module reach, communication blocking, combination value and responsiveness; robustness is reported separately as an uncertainty diagnostic. Their direction-aligned, within-candidate-set weighted mean defines the virtual perturbation priority score (VPPS), which is a relative ranking rather than a transportable clinical utility score. In a known 22-node, four-module generating network, analytical efficacy agreed with 100,000-draw Monte Carlo estimates within 0.0024 standard deviations. The reported finite-sample VPPS results were generated with the original eight-component exploratory score and therefore require regeneration under the revised seven-utility-dimension definition. These simulations provide internal computational verification under model compatibility, not causal or external validation. SymPerturb is intended to generate auditable target hypotheses for longitudinal and experimental testing.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Covasim: an agent-based model of COVID-19 dynamics and interventions 92%
- Combination Treatment Optimization Using aPan-Cancer Pathway Model 92%
- Contrasting model mechanisms of alanine aminotransferase (ALT) release from damaged and necrotic hepatocytes as an example of general biomarker mechanisms 92%
Similar papers in this journal
Similar papers in this journal
- Comparison of Bayesian networks, G-estimation and linear models to estimate causal treatment effects in aggregated N-of-1 trials 93%
- Prediction-powered Inference for Clinical Trials 91%
- Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA score 91%
Similar papers in this journal
- Was R < 1 before the English lockdowns? On modelling mechanistic detail, causality and inference about Covid-19 91%
- Enabling Transparent Toxicokinetic Modeling for Public Health Risk Assessment 91%
- Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.